Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression

BACKGROUND: The relationship between proton-pump inhibitor (PPI) use and chronic kidney disease (CKD) progression remains controversial. Specifically, there is a lack of data evaluating renal outcomes in established CKD patients. The aim of our study is to determine the risk of progression to end-st...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholin, Liza, Ashour, Tarek, Mehdi, Ali, Taliercio, Jonathan J., Daou, Remy, Arrigain, Susana, Schold, Jesse D., Thomas, George, Nally, Joseph, Nakhoul, Nazih L., Nakhoul, Georges N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281649/
https://www.ncbi.nlm.nih.gov/pubmed/34266395
http://dx.doi.org/10.1186/s12882-021-02449-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281649/
https://www.ncbi.nlm.nih.gov/pubmed/34266395
http://dx.doi.org/10.1186/s12882-021-02449-0

Ejemplares similares